Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
37563101000001113 | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
37563201000001118 | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lasilactone capsules (Waymade Ltd) 30 capsule | Is a | True | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Inferred relationship | Existential restriction modifier | |
Lasilactone capsules (Dowelhurst Ltd) 30 capsule | Is a | True | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Inferred relationship | Existential restriction modifier | |
Lasilactone capsules (Sigma Pharmaceuticals Plc) 30 capsule | Is a | True | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Inferred relationship | Existential restriction modifier | |
Lasilactone capsules (Lexon (UK) Ltd) 30 capsule | Is a | True | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Inferred relationship | Existential restriction modifier | |
Lasilactone capsules (Mawdsley-Brooks & Company Ltd) 30 capsule | Is a | True | Spironolactone 50mg / Furosemide 20mg capsules 30 capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets